Clinical Rheumatology

, Volume 37, Issue 11, pp 2999–3007 | Cite as

Diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus: a meta-analysis

  • Zi-Wei Dai
  • Hong Wang
  • Wen-Juan Xu
  • Zhi-Hui Wang
  • Sheng-Qian Xu
  • Bin WangEmail author
  • Dong-Qing YeEmail author
Original Article


To systematically evaluate the diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus (SLE). Studies were searched in PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), and China Biology Medicine (CBM) disc database, and languages were limited in English and Chinese. QUADAS-2 tool was applied to assess the quality of eligible studies. Random-effect model was applied to calculate pooled effects of miRNAs on diagnosing SLE. Subgroup analysis was used to explore the sources of heterogeneity. All data were calculated and analyzed by Meta-Disc 1.4 and RevMan 5.3 software. Six eligible studies were included in this meta-analysis. The pooled sensitivity, specificity, and diagnostic odds ratio of miRNAs were 0.75(95% CI 0.71–0.79), 0.72(95% CI 0.66–0.78), and 8.79(95% CI 4.91–15.73), respectively. The pooled positive likelihood ratio was 2.71(95% CI 2.20–3.33) and negative likelihood ratio was 0.34(95% CI 0.24–0.48). The area under the curve was 0.787. The subgroup analysis showed that the number of healthy controls might be the sources of heterogeneity. MiRNAs in blood have moderate accuracy and influence on diagnosing SLE, and the exact diagnostic value should be confirmed by further studies.


Diagnosis Meta-analysis MiRNAs Systemic lupus erythematosus 



This study was supported by Grants National Natural Science Foundation of China (No. 81573217, 81172764), and Scientific Research of BSKY from Anhui Medical University (No. XJ201301).

Compliance with ethical standards




  1. 1.
    Diniz-da-Costa T, Centeno M, Pinto L, Marques A, Mendes-Graca L (2012) Systemic lupus erythematosus and pregnancy. Acta medica portuguesa 25(6):448–453PubMedGoogle Scholar
  2. 2.
    Ahmadpoor P, Dalili N, Rostami M (2014) An update on pathogenesis of systemic lupus erythematosus. Iranian journal of kidney diseases 8(3):171–184PubMedGoogle Scholar
  3. 3.
    Pradhan V, Patwardhan M, Rajadhyaksha A, Ghosh K (2013) Clinical and immunological profile of systemic lupus erythematosus. Indian Pediatr 50(4):405–407CrossRefGoogle Scholar
  4. 4.
    Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M (2015) The diagnosis and treatment of systemic lupus erythematosus. Deutsches Arzteblatt international 112(25):423–432. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Adinolfi A, Valentini E, Calabresi E, Tesei G, Signorini V, Barsotti S, Tani C (2016) One year in review 2016: systemic lupus erythematosus. Clin Exp Rheumatol 34(4):569–574PubMedGoogle Scholar
  6. 6.
    Yu C, Gershwin ME, Chang C (2014) Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 48-49:10–13. CrossRefGoogle Scholar
  7. 7.
    Oku K, Atsumi T, Akiyama Y, Amano H, Azuma N, Bohgaki T, Asanuma YF, Horita T, Hosoya T, Ichinose K, Kato M, Katsumata Y, Kawaguchi Y, Kawakami A, Koga T, Kohsaka H, Kondo Y, Kubo K, Kuwana M, Mimori A, Mimori T, Mimura T, Murakami K, Nakano K, Nakayamada S, Ogishima H, Ohmura K, Saito K, Sano H, Shibuya M, Takahashi Y, Takasaki Y, Takeuchi T, Tamura N, Tanaka Y, Tsuboi H, Tsunoda S, Yukawa N, Yamakawa N, Yamamoto K, Sumida T (2017) Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC). Mod Rheumatol:1–7. CrossRefGoogle Scholar
  8. 8.
    Wichainun R, Kasitanon N, Wangkaew S, Hongsongkiat S, Sukitawut W, Louthrenoo W (2013) Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems. Asian Pac J Allergy Immunol 31(4):292–298. CrossRefPubMedGoogle Scholar
  9. 9.
    Flechsig A, Rose T, Barkhudarova B, Strauss R, Klotsche J, Dähnrich C, Schlumberger W, Enghard P, Burmester GR, Hiepe F, Biesen R (2017) What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3. Clin Exp Rheumatol 35:598–606Google Scholar
  10. 10.
    Parkpian V, Verasertniyom O, Vanichapuntu M, Totemchokchyakarn K, Nantiruj K, Pisitkul P, Angchaisuksiri P, Archararit N, Rachakom B, Ayurachai K, Janwityanujit S (2007) Specificity and sensitivity of anti-β2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome. Clin Rheumatol 26:1663–1670. CrossRefPubMedGoogle Scholar
  11. 11.
    Hausser J, Syed AP, Selevsek N, van Nimwegen E, Jaskiewicz L, Aebersold R, Zavolan M (2013) Timescales and bottlenecks in miRNA-dependent gene regulation. Mol Syst Biol 9:711. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lenkala D, Gamazon ER, LaCroix B, Im HK, Huang RS (2015) MicroRNA biogenesis and cellular proliferation. Translational research : the journal of laboratory and clinical medicine 166(2):145–151. CrossRefGoogle Scholar
  13. 13.
    Georgi N, Taipaleenmaki H, Raiss CC, Groen N, Portalska KJ, van Blitterswijk C, de Boer J, Post JN, van Wijnen AJ, Karperien M (2015) MicroRNA levels as prognostic markers for the differentiation potential of human mesenchymal stromal cell donors. Stem Cells Dev 24(16):1946–1955. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, Mansuria S, Elishaev E, Budiu R, Edwards RP, Huang X (2013) Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 19(5):1213–1224. CrossRefGoogle Scholar
  15. 15.
    Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, Rosenwaks Z, Tuschl T (2013) Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A 110(11):4255–4260. CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Ono S, Oyama T, Lam S, Chong K, Foshag LJ, Hoon DS (2015) A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients. Oncotarget 6(9):7053–7064. CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Filkova M, Aradi B, Senolt L, Ospelt C, Vettori S, Mann H, Filer A, Raza K, Buckley CD, Snow M, Vencovsky J, Pavelka K, Michel BA, Gay RE, Gay S, Jungel A (2014) Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis 73(10):1898–1904. CrossRefPubMedGoogle Scholar
  18. 18.
    Li M, Zhang J (2015) Circulating MicroRNAs: potential and emerging biomarkers for diagnosis of cardiovascular and cerebrovascular diseases. Biomed Res Int 2015:730535. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Thirion M, Ochiya T (2013) Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses 5(11):2690–2703. CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Peng Y, Li C, Luo DC, Ding JW, Zhang W, Pan G (2014) Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma. Molecules (Basel, Switzerland) 19(8):11586–11599. CrossRefGoogle Scholar
  21. 21.
    Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536. CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Dinnes J, Deeks J, Kirby J, Roderick P (2005) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health technology assessment (Winchester, England) 9(12):1–113 iii Google Scholar
  23. 23.
    Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM (2008) Systematic reviews of diagnostic test accuracy. Ann Intern Med 149(12):889–897CrossRefGoogle Scholar
  24. 24.
    Navarro-Quiroz E, Pacheco-Lugo L, Lorenzi H, Diaz-Olmos Y, Almendrales L, Rico E, Navarro R, Espana-Puccini P, Iglesias A, Egea E, Aroca G (2016) High-throughput sequencing reveals circulating miRNAs as potential biomarkers of kidney damage in patients with systemic lupus erythematosus. PLoS One 11(11):e0166202. CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Motawi TK, Mohsen DA, El-Maraghy SA, Kortam MA (2016) MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus. Chem Biol Interact 260:110–116. CrossRefPubMedGoogle Scholar
  26. 26.
    Tang ZM, Fang M, Wang JP, Cai PC, Wang P, Hu LH (2014) Clinical relevance of plasma miR-21 in new-onset systemic lupus erythematosus patients. J Clin Lab Anal 28(6):446–451. CrossRefPubMedGoogle Scholar
  27. 27.
    Lu YL, FAN CF, Xi HX, Qiang GG, Di ZH, Fang ZL, Ai LQ, Yang XX (2016) Detection of the plasma miR-23a expression in systemic lupus erythematosus and its clinical significance. Journal of Wenzhou Medical University 46(3):168–173. CrossRefGoogle Scholar
  28. 28.
    Yang H, Song GX, Ping W (2016) Changes in levels of serum miR-155 in patients with systemic lupus erythematosus. Shandong Medical Journal 56(45):27–30. CrossRefGoogle Scholar
  29. 29.
    Juan XL, Lu YL, Qiong CA, Xi HX, Di ZH, Sheng CC, Yang XX (2015) Expression of miR-29a in plasma of patients with systemic lupus erythematosus and its clinical significance. Zhejiang Medical Journal 37(19):1565–1569Google Scholar
  30. 30.
    Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148(6):1172–1187. CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Noonan EJ, Place RF, Basak S, Pookot D, Li LC (2010) miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1(5):349–358. CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Dumortier O, Hinault C, Van Obberghen E (2013) MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab 18(3):312–324. CrossRefPubMedGoogle Scholar
  33. 33.
    Tunnicliffe DJ, Singh-Grewal D, Kim S, Craig JC, Tong A (2015) Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines. Arthritis care & research 67(10):1440–1452. CrossRefGoogle Scholar
  34. 34.
    Choi J, Kim ST, Craft J (2012) The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol 24(6):651–657. CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Kamen DL (2014) Environmental influences on systemic lupus erythematosus expression. Rheum Dis Clin N Am 40(3):401–412, vii. CrossRefGoogle Scholar
  36. 36.
    Lai NS, Yu HC, Chen HC, Yu CL, Huang HB, Lu MC (2013) Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol 173(1):47–57. CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Maurer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O (2010) MicroRNA-29: a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62(6):1733–1743. CrossRefPubMedGoogle Scholar
  38. 38.
    Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10(4):R101. CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Pauley KM, Cha S, Chan EK (2009) MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 32(3–4):189–194. CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Lech M, Anders HJ (2013) The pathogenesis of lupus nephritis. J Am Soc Nephrol: JASN 24(9):1357–1366. CrossRefPubMedGoogle Scholar
  41. 41.
    McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating MicroRNA: preanalytical and analytical challenges. Clin Chem 57(6):833–840. CrossRefPubMedGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2018

Authors and Affiliations

  1. 1.Department of Epidemiology and Biostatistics, School of Public HealthAnhui Medical University, Anhui Province Key Laboratory of Major Autoimmune DiseasesHefeiChina
  2. 2.Department of Rheumatology and ImmunologyThe First Affiliated Hospital of Anhui Medical UniversityHefeiChina

Personalised recommendations